Advancing Pharmacoequity in Atrial Fibrillation
Ischemic stroke is one of the most devastating consequences of atrial fibrillation (AF). Oral anticoagulation for stroke risk reduction in those at moderate to high risk is a cornerstone of AF management. Direct oral anticoagulants (DOACs) were first approved in the US in 2010 and have since…